Novoprotein
1 known investors
Novoprotein provides contract research services covering RNA workflows (including linear mRNA, circular RNA, and self-amplifying RNA synthesis, RNA-LNP encapsulation, and quality control), antibody development (phage display and hybridoma), protein expression across multiple host systems, and vaccine design and development. It serves biopharmaceutical and life-sciences researchers as a technology services platform.
Investors · 1
Frequently asked questions
- What does Novoprotein do?
- Novoprotein provides contract research services covering RNA workflows (including linear mRNA, circular RNA, and self-amplifying RNA synthesis, RNA-LNP encapsulation, and quality control), antibody development (phage display and hybridoma), protein expression across multiple host systems, and vaccine design and development. It serves biopharmaceutical and life-sciences researchers as a technology services platform.
- Who are Novoprotein's investors?
- Novoprotein's investors include Qiming Venture Partners.